BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37932117)

  • 21. Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far.
    Łusiak-Szelachowska M; Międzybrodzki R; Drulis-Kawa Z; Cater K; Knežević P; Winogradow C; Amaro K; Jończyk-Matysiak E; Weber-Dąbrowska B; Rękas J; Górski A
    J Biomed Sci; 2022 Mar; 29(1):23. PubMed ID: 35354477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.
    Royer S; Morais AP; da Fonseca Batistão DW
    Arch Microbiol; 2021 May; 203(4):1271-1279. PubMed ID: 33474609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Phage therapy, an additional strategy against multidrug-resistant bacteria].
    Boniver M; Wotquenne P; Moutschen M; Rousseau AF
    Rev Med Liege; 2022 Sep; 77(9):510-515. PubMed ID: 36082597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteriophages: what role may they play in life after spinal cord injury?
    Leitner L; McCallin S; Kessler TM
    Spinal Cord; 2021 Sep; 59(9):967-970. PubMed ID: 33963272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Phage therapy, an alternative to antibiotic therapy?)].
    Reina J; Reina N
    Rev Esp Quimioter; 2018 Apr; 31(2):101-104. PubMed ID: 29451376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Framing the Future with Bacteriophages in Agriculture.
    Svircev A; Roach D; Castle A
    Viruses; 2018 Apr; 10(5):. PubMed ID: 29693561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacteriophages and its applications: an overview.
    Sharma S; Chatterjee S; Datta S; Prasad R; Dubey D; Prasad RK; Vairale MG
    Folia Microbiol (Praha); 2017 Jan; 62(1):17-55. PubMed ID: 27718043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phage therapy pharmacology.
    Abedon ST; Thomas-Abedon C
    Curr Pharm Biotechnol; 2010 Jan; 11(1):28-47. PubMed ID: 20214606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.
    Malik DJ; Sokolov IJ; Vinner GK; Mancuso F; Cinquerrui S; Vladisavljevic GT; Clokie MRJ; Garton NJ; Stapley AGF; Kirpichnikova A
    Adv Colloid Interface Sci; 2017 Nov; 249():100-133. PubMed ID: 28688779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review.
    Uyttebroek S; Chen B; Onsea J; Ruythooren F; Debaveye Y; Devolder D; Spriet I; Depypere M; Wagemans J; Lavigne R; Pirnay JP; Merabishvili M; De Munter P; Peetermans WE; Dupont L; Van Gerven L; Metsemakers WJ
    Lancet Infect Dis; 2022 Aug; 22(8):e208-e220. PubMed ID: 35248167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prospects of using bacteriophages in urological practice].
    Shiryaev AA; Vasilyev AO; Zaitsev AV; Prilepskaya EA; Sazonova NA; Grigoryan IE; Kim YA; Pushkar DY
    Urologiia; 2019 Dec; (6):131-136. PubMed ID: 32003183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Review of Phage Therapy for Bone and Joint Infections.
    Ferry T
    Methods Mol Biol; 2024; 2734():207-235. PubMed ID: 38066372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paving the way for phage therapy using novel drug delivery approaches.
    Briot T; Kolenda C; Ferry T; Medina M; Laurent F; Leboucher G; Pirot F;
    J Control Release; 2022 Jul; 347():414-424. PubMed ID: 35569589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reapproaching Old Treatments: Considerations for PK/PD Studies on Phage Therapy for Bacterial Respiratory Infections.
    Schmalstig AA; Freidy S; Hanafin PO; Braunstein M; Rao GG
    Clin Pharmacol Ther; 2021 Jun; 109(6):1443-1456. PubMed ID: 33615463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Big Impact of the Tiny: Bacteriophage-Bacteria Interactions in Biofilms.
    Hansen MF; Svenningsen SL; Røder HL; Middelboe M; Burmølle M
    Trends Microbiol; 2019 Sep; 27(9):739-752. PubMed ID: 31128928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. European regulatory aspects of phage therapy: magistral phage preparations.
    Verbeken G; Pirnay JP
    Curr Opin Virol; 2022 Feb; 52():24-29. PubMed ID: 34801778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical data and safety assessment of phage therapy in humans.
    Nale JY; Clokie MR
    Curr Opin Biotechnol; 2021 Apr; 68():310-317. PubMed ID: 33862490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A century of phage therapy: from novel discoveries about the past to the challenges of the today.
    Bach-Rojecky L; Lacković Z
    Pharmazie; 2021 Oct; 76(10):519-521. PubMed ID: 34620283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibiotics.
    Usman SS; Uba AI; Christina E
    Mol Biol Rep; 2023 Aug; 50(8):7055-7067. PubMed ID: 37392288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacteriophages: the possible solution to treat infections caused by pathogenic bacteria.
    El-Shibiny A; El-Sahhar S
    Can J Microbiol; 2017 Nov; 63(11):865-879. PubMed ID: 28863269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.